My Account |

Human Apolipoprotein A-I (Apo A1) ELISA Kit (with Control)

Name: Human Apolipoprotein A-I (Apo A1) ELISA Kit (with Control)
Brand: AssayMax&trade; ELISA Kits
SKU: EA5201-7
Availability: InStock

$453.00

Catalog Number: EA5201-7

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EA5201-7 Categories: Competitive ELISA, ELISA Kits, Kits Tags: APO A1, ApoA-I, ApoA1, Apolipoprotein A-I(1-242), Apolipoprotein A1, ProapoA-I Brand: AssayMax™ ELISA Kits

Additional information

Format	Competitive ELISA
Entrez Gene	335
Components	Biotinylated Human Apolipoprotein A-I Protein, Chromogen Substrate (1x), Human Apolipoprotein A-I Microplate, Human Apolipoprotein A-I Standard, MIX Diluent Concentrate (10x), Positive Control, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)
TIme	2 hours
Sensitivity	0.12 µg/ml
Range	0.156 – 10 ug/ml
Samples Type	Plasma, Serum
Associated Disease	Cancer, Cardiovascular, Heart Disease, Metabolism
Species	Human
UniProt	P02647
Storage	Refer to component labels for details
Plex	1
Usage	For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications

"* Grover A et al. (2020) Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels. Cureus.12(1):e6542.
"* Eldeeb MA et al. (2020) Serum apolipoprotein A1: a predictor and prognostic biomarker in acute ischemic stroke. Egyp. J.Neurology Psychia. Neurosurgery. 56:3.
"* Cieluch A et al. (2020) Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study. Arch. Med. Sci. 18:1-8.
"* Tortorici MA et al. (2019) Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function. Clinical Pharmacology in Drug Development. 8(5):628-636
"* Lambert Goitia C (2019) Nutritional interventions in cardiovascular prevention and effects of risk factors on adipose tissue. University of Barcelona. Ph.D. Thesis.
"* Hussein A et al. (2019) Leptin and Tumor necrosis factor alpha in breast. SOHAG MED. J. 23(1):235-247.
"* Ahmed NS et al. (2019) Serum Syndecan-1 and Apolipoprotein A1 in patients with chronic HCV infection. Sohag Med. J. 23(2):2 Apr 2019.
"* El-Gendy FM et al. (2018) Diagnostic value of apolipoprotein A1 in neonatal sepsis. Menoufia Medical Journal. 31(3):1011-1017
"* Ebara S et al. (2018) Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus. J.Thrombo. Thrombolysis. 45(2):200?205.
"* Shree R et al. (2019) Role of DJ-1 and Apo A1 as biomarkers in Parkinson?s disease: an observational case-control study. Annals of Movement Disorders. 2(3):109-114.
"* Ray S et al. (2017) Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection. Sci Rep. 7(1):4400.
"* Ray S et al. (2017) Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria. Sci Rep. 6:24557.
"* Omar NN et al. (2017) Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM. Bulletin of Faculty of Pharmacy, Cairo University. 55(2): 325-331.
"* Limareva LV et al. (2017) Assessment of the relationship between markers of inflammation, adipokines and lipid metabolism parameters in overweight and obese individuals.
"* Grover A et al. (2017) Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients. Indian Heart J. 69(1):6-10.
"* Lambert C et al. (2017) Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study. Nutrients. 9(6):599.
"* Wu T et al. (2015) The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols. J Pharmacol Sci. 127(3):251-9. doi: 10.1016/j.jphs.2014.12.002. Epub 2014 Dec 15
"* Taylor JK (2015) Paraoxonase Responses to Exercise and Niacin Therapy in Men with Metabolic Syndrome. Redox Rep. 20(1):42-8.
"* Sharma S (2015) Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics. 15(2-3):394-407
"* Ray S et al. (2015) Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics. 127:103-113
"* Cubedo J et al. (2015) A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients. J Lipid Res. 56(9):1762-73.
"* Sharma S et al. (2014) Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers. Sci Rep. 4:7140. doi: 10.1038/srep07140
"* Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children. Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186
"* Cubedo J et al. (2014) Glycoproteome of human apolipoprotein AI: N-and O-glycosylated forms are increased in patients with acute myocardial infarction. Transl Res.164(3):209-22.
"* Wen Q et al. (2013) Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics. Biochem Biophys Res Commun. 438(3):473-8.
"* Wang DX et al. (2013) The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease. Chin Med J 126 (19): 3656-3661
"* Miyamoto-Sasaki M et al. (2013) Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. J Atheroscler Thromb. 20(9):708-16.
"* Ghorbanian B et al. (2013) The Effects of Eight Weeks Interval Endurance Robe Training on Lymphocyte ABCA1 Protein Expression, Plasma Apolipoprotein A-I and HDL-cin Overweight and Obese Boy Adolescents. Int J Endocrinol Metab. 2013 Spring;11(2):76-81
"* Flores JM (2013) Artificial neural network-based serum biomarkers analysis improves sensitivity in the diagnosis of lung cancer. IFMBE Proceedings. 33:882-885.
"* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1
"* Choi GS et al. (2013) Eosinophil activation and novel mediators in the aspirin?induced nasal response in AERD. Clin Exp Allergy. 43(7):730-40.
"* Bandarian F et al. (2013) Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels. Lipids. 48:1207-1216.
"* Larner CD (2012) High Performance Lipoprotein Profiling for Cardiovascular Risk Assessment. Texas A&M University.
"* Kootte RS et al. (2015) Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]. J Lipid Res. 56(3):703-712.
"* Charles-Schoeman C et al. (2012) Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 71(7):1157-1162
"* Vacirca D et al. (2011) Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level. J Alzheimers Dis. 26(3):441-445.
"* Ahmad Y et al. (2011) Identification of haptoglobin and apolipoprotein AI as biomarkers for high altitude pulmonary edema.Funct Integr Genomics. 11(3):407-17.
"* Ling XB et al. (2010) Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics. 2010 Dec;10(24):4415-30
"* Chen GL et al. (2010) High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease. Chin Med J (Engl). 123(6):658-663.

Human Apolipoprotein A-I (Apo A1) ELISA Kit (with Control)

Additional information

Documentation

Publications

Related products

Human Apolipoprotein A-I (Apo A1) ELISA Kit Positive Reference Plasma Control

Mouse Apolipoprotein A-I (Apo-A1) ELISA Kit

Human Apolipoprotein A-I (Apo A1) ELISA Kit

Human Apolipoprotein A-I (Apo A1) ELISA Kit